Skip to main content
OpenTrials
Suspended

NCT Number: NCT05842031

Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer

To learn more about the patient experience undergoing inguinal (in the groin) lymph node procedures for penile cancer during and after surgery.

Why the study stopped: PI requested
Suspended

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

MD Anderson

Houston, Texas, 77030, United States

About this study

Objectives

Primary Objective:

To understand the lived experience of patients undergoing invasive inguinal lymph node procedures.

Secondary Objective:

To determine factors that influence decisions and improve experience for patients who need invasive inguinal lymph node procedures.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

--Patients diagnosed with penile cancer who have undergone invasive inguinal node procedures (ILND and/or DSNB) and are at least 6 months post-procedure

Exclusion criteria

  • Patient's ≤18 years of age
  • Patients who have not undergone invasive surgical procedures involving the inguinal lymph nodes
  • Non-English-speaking patients For interviews: people who are physically and/or cognitively incapable of participating in a 60minute telephone interview as determined by a clinical provider or the patient.

Treatment and study plan

Quality of life questionnaires

Behavioral

Identify what interventions may be helpful in improving quality of life.

Patient Educational Needs

Behavioral

Identify what interventions may be helpful in improving patient educational needs

symptom management

Behavioral

Identify what interventions may be helpful in improving symptom management Improve symptom management

Primary outcomes

  1. Decision Regret Scale (DRS) questionnaires

    Time frame: through study completion; an average of 1 year

    Score Scale ranges (1-5)

    • Strongly Agree
    • Agree
    • Agree nor Disagree
    • Disagree
    • Strongly Disagree

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
May 3, 2023
Registry last updated
Aug 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.